Breast Carcinoma: Clinical Trials

46 trials for Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 13 recruiting, 6 terminated, 5 active not recruiting. 46 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 246Completed 14, Recruiting 13, Terminated 6, Active not recruiting 5, Withdrawn 5, Unknown 2, Enrolling by invitation 1
Phase 14Completed 2, Recruiting 1, Withdrawn 1
Phase 32Completed 1, Terminated 1

Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma
Phase 2RecruitingMayo Clinic272025-12-182026-09-30
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy
Phase 2RecruitingCity of Hope Medical Center1202025-10-032025-12-05
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingCity of Hope Medical Center822025-08-282026-10-30
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Biospecimen Collection, Mammography, Omega-3-Acid Ethyl Esters - Breast Atypical Hyperplasia, Breast Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)662025-07-282026-08-04
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Biopsy of Breast, Biospecimen Collection, Breast Surgery - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingMayo Clinic1202025-05-142026-09-03
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Biospecimen Collection, Oligo-fucoidan, Placebo Administration - Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm
Phase 2RecruitingMayo Clinic342025-03-062026-10-16
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Acolbifene Hydrochloride, Biospecimen Collection, Mammography - Breast Atypical Hyperplasia, Breast Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)802024-10-102026-11-18
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Biopsy Procedure, Biospecimen Collection, Mammography - Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia
Phase 2RecruitingNational Cancer Institute (NCI)2002024-09-272026-07-27
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Breast Cancer, Breast Carcinoma
Phase 1 / Phase 2RecruitingEssen Biotech852024-08-222024-11-12
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I
Phase 2RecruitingUniversity of California, Davis862024-08-152026-03-04
EMBRACE: Exercising Together
Exercise Intervention, Biospecimen Collection, Educational Intervention - Breast Carcinoma, Prostate Carcinoma
Phase 2RecruitingOHSU Knight Cancer Institute4002024-04-182026-10-13
Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy
Alginos Oral Suspension - Breast Carcinoma
Phase 2Enrolling by invitationTaipei City Hospital902024-02-152025-05-06
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy
eftilagimod alpha, Paclitaxel, placebo - Breast Carcinoma
Phase 2 / Phase 3TerminatedImmutep S.A.S.722023-05-222026-07-30
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration - Breast Carcinoma
Phase 2RecruitingMayo Clinic602023-03-092026-10-01
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer
Computed Tomography, Fluorine F 18 Fluorthanatrace, Positron Emission Tomography - Breast Carcinoma
Phase 2Active not recruitingM.D. Anderson Cancer Center362023-02-272026-06-12
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
Adaptive Aerobic Training/AT Dosing, Standard (fixed) Aerobic Training/AT dosing - Breast Cancer, Breast Carcinoma
Phase 2RecruitingMemorial Sloan Kettering Cancer Center1402023-01-302026-08-27
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
NUV-422, Fulvestrant - Advanced Breast Cancer, Metastatic Breast Cancer
Phase 1 / Phase 2WithdrawnNuvation Bio Inc.2022-09-012023-07-11
Therapeutic Dose Monitoring (TDM) of Tamoxifen
Tamoxifen 20 mg - Breast Cancer, Breast Carcinoma
Phase 2UnknownKarolinska University Hospital402022-04-042022-05-25
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
Anastrozole 1mg, Letrozole 2.5mg, Exemestane 25 mg - Breast Cancer, HER2-negative Breast Cancer
Phase 2CompletedIrada Ibrahim-zada82022-02-182026-08-31
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Cimetidine, Dexamethasone, Diphenhydramine - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Phase 2 / Phase 3CompletedOhio State University Comprehensive Cancer Center1302021-10-072025-08-20

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (46)  ·  Breast Carcinoma In Situ (6)  ·  Ovarian Neoplasms (5)  ·  Triple Negative Breast Neoplasms (4)  ·  Carcinoma, Intraductal, Noninfiltrating (3)  ·  Lung Neoplasms (3)  ·  Prostatic Neoplasms (3)  ·  Uterine Cervical Neoplasms (3)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Renal Cell (2)  ·  Colonic Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Hematologic Neoplasms (2)

Broader conditions

Breast Diseases (46)  ·  Neoplasms (46)  ·  Neoplasms by Site (46)  ·  Skin Diseases (46)  ·  Skin and Connective Tissue Diseases (46)  ·  Neoplasms by Histologic Type (10)  ·  Carcinoma (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Carcinoma in Situ (6)  ·  Genital Diseases (6)  ·  Urogenital Diseases (6)  ·  Urogenital Neoplasms (6)  ·  Adenocarcinoma (5)  ·  Adnexal Diseases (5)  ·  Digestive System Diseases (5)

Interventions

Specimen Handling (9)  ·  Tamoxifen (7)  ·  Paclitaxel (6)  ·  Letrozole (5)  ·  Fulvestrant (4)  ·  Magnetic Resonance Spectroscopy (4)  ·  Trastuzumab (4)  ·  palbociclib (4)  ·  Biopsy (3)  ·  Carboplatin (2)  ·  Goserelin (2)  ·  MLN 8237 (2)  ·  Mastectomy, Segmental (2)  ·  Nivolumab (2)  ·  Taxes (2)

Sponsors

Mayo Clinic (6)  ·  National Cancer Institute (NCI) (4)  ·  City of Hope Medical Center (2)  ·  M.D. Anderson Cancer Center (2)  ·  OHSU Knight Cancer Institute (2)  ·  Washington University School of Medicine (2)  ·  Academic and Community Cancer Research United (1)  ·  American Scitech International (1)  ·  Andrei Iagaru (1)  ·  Antisoma Research (1)  ·  Catalysis SL (1)  ·  Clinique Clementville (1)  ·  Dawn L. Hershman (1)  ·  Essen Biotech (1)  ·  Gary Morrow (1)

Countries

United States (37)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Cuba (1)  ·  France (1)  ·  Georgia (1)  ·  Guam (1)  ·  Moldova (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Amy Degnim, M.D. (1)  ·  Andrei Iagaru (1)  ·  Azadeh Nasrazadani (1)  ·  Carlos E. Vargas, MD (1)  ·  Carol J Fabian (1)  ·  Charles Loprinzi (1)  ·  Cynthia X Ma, M.D., Ph.D. (1)  ·  David B. Page, MD (1)  ·  Dawn Hershman, MD, MS (1)  ·  Debra Barton (1)  ·  Dennis Holmes (1)  ·  Elham Hedayati, MD PhD (1)  ·  Eve Rodler, MD (1)  ·  Foluso O Ademuyiwa, M.D, MPH (1)

Results publications

PMID 21878535, PMID 26586415, PMID 30347019, PMID 32463741, PMID 33048619, PMID 33877311, PMID 34882500, PMID 35133871, PMID 35138919, PMID 35314693, PMID 36351402, PMID 36410913, PMID 36609389, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38591867, PMID 39558017, PMID 39666929, PMID 39693587, PMID 39913886, PMID 40443562, PMID 40865033, PMID 41066729

NIH funding

UG1CA242632 (3), P30CA033572 (2), P30CA046592 (2), 2009 (1), P30CA014520 (1), P30CA015083 (1), P30CA060553 (1), P30CA069533 (1), R01CA237607 (1), R01CA258717 (1), R01CA262393 (1), R01CA277738 (1), R21CA178648 (1), U01CA168426 (1), U10CA180820 (1)